Overdiagnosis in early detection programs

被引:29
作者
Davidov, O
Zelen, M
机构
[1] Univ Haifa, Dept Stat, IL-31905 Haifa, Israel
[2] Harvard Univ, Dept Biostat, Boston, MA 02115 USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
关键词
early detection programs; overdiagnosis; screening;
D O I
10.1093/biostatistics/kxh012
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Overdiagnosis refers to the situation where a screening exam detects a disease that would have otherwise been undetected in a person's lifetime. The disease would have not have been diagnosed because the individual would have died of other causes prior to its clinical onset. Although the probability of overdiagnosis is an important quantity for understanding early detection programs it has not been rigorously studied. We analyze an idealized early detection program and derive the mathematical expression for the probability of overdiagnosis. The results are studied numerically for prostate cancer and applied to a variety of screening schedules. Our investigation indicates that the probability of overdiagnosis is remarkably high.
引用
收藏
页码:603 / 613
页数:11
相关论文
共 26 条
[1]   Overdiagnosis: An underrecognized cause of confusion and harm in cancer screening [J].
Black, WC .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (16) :1280-1282
[2]  
Bostwick D G, 1999, Semin Urol Oncol, V17, P199
[3]   Prostate cancer screening: the problem of overdiagnosis and lessons to be learned from breast cancer screening [J].
Ciatto, S ;
Zappa, M ;
Bonardi, R ;
Gervasi, G .
EUROPEAN JOURNAL OF CANCER, 2000, 36 (11) :1347-1350
[4]  
Davidov O, 1999, APPL STOCH MODEL D A, V15, P55, DOI 10.1002/(SICI)1099-0747(199903)15:1<55::AID-ASM358>3.3.CO
[5]  
2-W
[6]   The theory of case-control studies for early detection programs [J].
Davidov, O ;
Zelen, M .
BIOSTATISTICS, 2003, 4 (03) :411-421
[7]   Prostate cancer mortality reduction by screening:: Power and time frame with complete enrollment in the European Randomised Screening for Prostate Cancer (ERSPC) trial [J].
de Koning, HJ ;
Liem, MK ;
Baan, CA ;
Boer, R ;
Schröder, FH ;
Alexander, FE .
INTERNATIONAL JOURNAL OF CANCER, 2002, 98 (02) :268-273
[8]  
Etzioni R, 1998, AM J EPIDEMIOL, V148, P775
[9]  
Etzioni R, 2002, J NATL CANCER I, V94, P981
[10]   A PROSPECTIVE EVALUATION OF PLASMA PROSTATE-SPECIFIC ANTIGEN FOR DETECTION OF PROSTATIC-CANCER [J].
GANN, PH ;
HENNEKENS, CH ;
STAMPFER, MJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (04) :289-294